Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Robert Pirker; Jose Pereira; Aleksandra Szczesna; Joachim von Pawel; Maciej Krzakowski; Rodryg Ramlau; Ihor Vynnychenko; Keunchil Park; Chih-Teng Yu; Valentyn Ganul; Jae-Kyung Roh; Emilio Bajetta; Kenneth O'Byrne; Fillipo de Marinis; Wilfried Eberhardt; Thomas Goddemeier; Michael Emig; Ulrich Gatzemeier; A Alavez; F Coppola; G Recondo; E Richardet; F Kirsten; C Karapetis

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Robert Pirker, Jose Pereira, Aleksandra Szczesna, Joachim von Pawel, Maciej Krzakowski, Rodryg Ramlau, Ihor Vynnychenko, Keunchil Park, Chih-Teng Yu, Valentyn Ganul, Jae-Kyung Roh, Emilio Bajetta, Kenneth O'Byrne, Fillipo de Marinis, Wilfried Eberhardt, Thomas Goddemeier, Michael Emig, Ulrich Gatzemeier, A Alavez, F CoppolaG Recondo, E Richardet, F Kirsten, C Karapetis

Research output: Contribution to journal › Article › peer-review

1257 Citations (Scopus)

Original language	English
Pages (from-to)	1525-1531
Number of pages	7
Journal	Lancet
Volume	373
Issue number	9674
Publication status	Published - 2009

Cite this

Pirker, R., Pereira, J., Szczesna, A., von Pawel, J., Krzakowski, M., Ramlau, R., Vynnychenko, I., Park, K., Yu, C-T., Ganul, V., Roh, J-K., Bajetta, E., O'Byrne, K., de Marinis, F., Eberhardt, W., Goddemeier, T., Emig, M., Gatzemeier, U., Alavez, A., ... Karapetis, C. (2009). Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet, 373(9674), 1525-1531.

@article{aab7ac3c10e240a1a1f1c04a8bb5ea18,

title = "Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial",

author = "Robert Pirker and Jose Pereira and Aleksandra Szczesna and {von Pawel}, Joachim and Maciej Krzakowski and Rodryg Ramlau and Ihor Vynnychenko and Keunchil Park and Chih-Teng Yu and Valentyn Ganul and Jae-Kyung Roh and Emilio Bajetta and Kenneth O'Byrne and {de Marinis}, Fillipo and Wilfried Eberhardt and Thomas Goddemeier and Michael Emig and Ulrich Gatzemeier and A Alavez and F Coppola and G Recondo and E Richardet and F Kirsten and C Karapetis",

year = "2009",

language = "English",

volume = "373",

pages = "1525--1531",

journal = "Lancet",

issn = "0140-6736",

publisher = "Lancet",

number = "9674",

}

Pirker, R, Pereira, J, Szczesna, A, von Pawel, J, Krzakowski, M, Ramlau, R, Vynnychenko, I, Park, K, Yu, C-T, Ganul, V, Roh, J-K, Bajetta, E, O'Byrne, K, de Marinis, F, Eberhardt, W, Goddemeier, T, Emig, M, Gatzemeier, U, Alavez, A, Coppola, F, Recondo, G, Richardet, E, Kirsten, F & Karapetis, C 2009, 'Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial', Lancet, vol. 373, no. 9674, pp. 1525-1531.

TY - JOUR

T1 - Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

AU - Pirker, Robert

AU - Pereira, Jose

AU - Szczesna, Aleksandra

AU - von Pawel, Joachim

AU - Krzakowski, Maciej

AU - Ramlau, Rodryg

AU - Vynnychenko, Ihor

AU - Park, Keunchil

AU - Yu, Chih-Teng

AU - Ganul, Valentyn

AU - Roh, Jae-Kyung

AU - Bajetta, Emilio

AU - O'Byrne, Kenneth

AU - de Marinis, Fillipo

AU - Eberhardt, Wilfried

AU - Goddemeier, Thomas

AU - Emig, Michael

AU - Gatzemeier, Ulrich

AU - Alavez, A

AU - Coppola, F

AU - Recondo, G

AU - Richardet, E

AU - Kirsten, F

AU - Karapetis, C

PY - 2009

Y1 - 2009

M3 - Article

VL - 373

SP - 1525

EP - 1531

JO - Lancet

JF - Lancet

SN - 0140-6736

IS - 9674

ER -